Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wei-Jian Ni

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Diabetes/Metabolism Research and Reviews|June 6, 2014
Research progress in signalling pathway in diabetic nephropathyWei-Jian Ni, Li-Qin Tang, Wei Wei
European Journal of Pharmacology|April 28, 2015
Berberine as a promising anti-diabetic nephropathy drug: An analysis of its effects and mechanismsWei-Jian Ni, Hai-Hua Ding, Li-Qin Tang
Frontiers in Cell and Developmental Biology|February 11, 2021
MicroRNAs as Regulators of Immune and Inflammatory Responses: Potential Therapeutic Targets in Diabetic NephropathyHong Zhou, Wei-Jian Ni, Xiao-Ming Meng, et al.
Journal of Receptor and Signal Transduction Research|December 18, 2015
G protein-coupled receptors: potential therapeutic targets for diabetic nephropathyHai-Hua Ding, Wei-Jian Ni, Li-Qin Tang, et al.
Journal of Diabetes Investigation|July 24, 2019
Berberine ameliorates renal impairment and inhibits podocyte dysfunction by targeting the phosphatidylinositol 3-kinase-protein kinase B pathway in diabetic ratsWei-Jian Ni, Hong Zhou, Hai-Hua Ding, et al.
Frontiers in Cell and Developmental Biology|March 18, 2022
Corrigendum: MicroRNAs as Regulators of Immune and Inflammatory Responses: Potential Therapeutic Targets in Diabetic NephropathyHong Zhou, Wei-Jian Ni, Xiao-Ming Meng, et al.
Chinese Medicine|June 3, 2020
The potential insights of Traditional Chinese Medicine on treatment of COVID-19Tong Tong, Ying-Qi Wu, Wei-Jian Ni, et al.
Frontiers in Pharmacology|April 2, 2021
Research Progress of Therapeutic Enzymes and Their Derivatives: Based on Herbal Medicinal Products in Rheumatoid ArthritisMing Cai, Wei-Jian Ni, Lan Han, et al.
Frontiers in Cell and Developmental Biology|November 15, 2021
Advances in RNA Epigenetic Modifications in Hepatocellular Carcinoma and Potential Targeted Intervention StrategiesLi-Ran Zhu, Wei-Jian Ni, Ming Cai, et al.
Frontiers in Oncology|June 23, 2022
Targeting TMEM88 as an Attractive Therapeutic Strategy in Malignant TumorsMing Cai, Wei-Jian Ni, Ying-Hong Wang, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Diabetes/Metabolism Research and Reviews|June 6, 2014
Research progress in signalling pathway in diabetic nephropathyWei-Jian Ni, Li-Qin Tang, Wei Wei
European Journal of Pharmacology|April 28, 2015
Berberine as a promising anti-diabetic nephropathy drug: An analysis of its effects and mechanismsWei-Jian Ni, Hai-Hua Ding, Li-Qin Tang
Frontiers in Cell and Developmental Biology|February 11, 2021
MicroRNAs as Regulators of Immune and Inflammatory Responses: Potential Therapeutic Targets in Diabetic NephropathyHong Zhou, Wei-Jian Ni, Xiao-Ming Meng, et al.
Journal of Receptor and Signal Transduction Research|December 18, 2015
G protein-coupled receptors: potential therapeutic targets for diabetic nephropathyHai-Hua Ding, Wei-Jian Ni, Li-Qin Tang, et al.
Journal of Diabetes Investigation|July 24, 2019
Berberine ameliorates renal impairment and inhibits podocyte dysfunction by targeting the phosphatidylinositol 3-kinase-protein kinase B pathway in diabetic ratsWei-Jian Ni, Hong Zhou, Hai-Hua Ding, et al.
Frontiers in Cell and Developmental Biology|March 18, 2022
Corrigendum: MicroRNAs as Regulators of Immune and Inflammatory Responses: Potential Therapeutic Targets in Diabetic NephropathyHong Zhou, Wei-Jian Ni, Xiao-Ming Meng, et al.
Chinese Medicine|June 3, 2020
The potential insights of Traditional Chinese Medicine on treatment of COVID-19Tong Tong, Ying-Qi Wu, Wei-Jian Ni, et al.
Frontiers in Pharmacology|April 2, 2021
Research Progress of Therapeutic Enzymes and Their Derivatives: Based on Herbal Medicinal Products in Rheumatoid ArthritisMing Cai, Wei-Jian Ni, Lan Han, et al.
Frontiers in Cell and Developmental Biology|November 15, 2021
Advances in RNA Epigenetic Modifications in Hepatocellular Carcinoma and Potential Targeted Intervention StrategiesLi-Ran Zhu, Wei-Jian Ni, Ming Cai, et al.
Frontiers in Oncology|June 23, 2022
Targeting TMEM88 as an Attractive Therapeutic Strategy in Malignant TumorsMing Cai, Wei-Jian Ni, Ying-Hong Wang, et al.
Pageof 4